Literature DB >> 30622327

An Amish founder variant consolidates disruption of CEP55 as a cause of hydranencephaly and renal dysplasia.

Lettie E Rawlins1,2, Hannah Jones1, Olivia Wenger3, Myat Aye1, James Fasham1,2, Gaurav V Harlalka1, Barry A Chioza1, Alexander Miron4, Sian Ellard1, Matthew Wakeling1, Andrew H Crosby5, Emma L Baple6,7.   

Abstract

The centrosomal protein 55 kDa (CEP55 (OMIM 610000)) plays a fundamental role in cell cycle regulation and cytokinesis. However, the precise role of CEP55 in human embryonic growth and development is yet to be fully defined. Here we identified a novel homozygous founder frameshift variant in CEP55, present at low frequency in the Amish community, in two siblings presenting with a lethal foetal disorder. The features of the condition are reminiscent of a Meckel-like syndrome comprising of Potter sequence, hydranencephaly, and cystic dysplastic kidneys. These findings, considered alongside two recent studies of single families reporting loss of function candidate variants in CEP55, confirm disruption of CEP55 function as a cause of this clinical spectrum and enable us to delineate the cardinal clinical features of this disorder, providing important new insights into early human development.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30622327      PMCID: PMC6420058          DOI: 10.1038/s41431-018-0306-0

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

1.  Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis.

Authors:  Wei-meng Zhao; Akiko Seki; Guowei Fang
Journal:  Mol Biol Cell       Date:  2006-06-21       Impact factor: 4.138

2.  Hydranencephaly; clinical diagnosis; presentation of 7 cases.

Authors:  W B HAMBY; R F KRAUSS; W F BESWICK
Journal:  Pediatrics       Date:  1950-09       Impact factor: 7.124

3.  Meckel-Gruber Syndrome: a population-based study on prevalence, prenatal diagnosis, clinical features, and survival in Europe.

Authors:  Ingeborg Barisic; Ljubica Boban; Maria Loane; Ester Garne; Diana Wellesley; Elisa Calzolari; Helen Dolk; Marie-Claude Addor; Jorieke Eh Bergman; Paula Braz; Elizabeth S Draper; Martin Haeusler; Babak Khoshnood; Kari Klungsoyr; Anna Pierini; Annette Queisser-Luft; Judith Rankin; Anke Rissmann; Christine Verellen-Dumoulin
Journal:  Eur J Hum Genet       Date:  2014-09-03       Impact factor: 4.246

4.  A nonsense mutation in CEP55 defines a new locus for a Meckel-like syndrome, an autosomal recessive lethal fetal ciliopathy.

Authors:  M-L Bondeson; K Ericson; S Gudmundsson; A Ameur; F Pontén; J Wesström; C Frykholm; M Wilbe
Journal:  Clin Genet       Date:  2017-05-03       Impact factor: 4.438

5.  Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis.

Authors:  Megan Fabbro; Bin-Bing Zhou; Mikiko Takahashi; Boris Sarcevic; Preeti Lal; Mark E Graham; Brian G Gabrielli; Phillip J Robinson; Erich A Nigg; Yoshitaka Ono; Kum Kum Khanna
Journal:  Dev Cell       Date:  2005-10       Impact factor: 12.270

6.  FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway.

Authors:  C-H Chen; P-J Lu; Y-C Chen; S-L Fu; K-J Wu; A-P Tsou; Y-C G Lee; T-C E Lin; S-L Hsu; W-J Lin; C-Y F Huang; C-K Chou
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

7.  Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in CEP55.

Authors:  Hyung Ho Lee; Natalie Elia; Rodolfo Ghirlando; Jennifer Lippincott-Schwartz; James H Hurley
Journal:  Science       Date:  2008-10-24       Impact factor: 47.728

8.  Lethal cystic kidney disease in Amish neonates associated with homozygous nonsense mutation of NPHP3.

Authors:  Michael A Simpson; Harold E Cross; Leroy Cross; Mervin Helmuth; Andrew H Crosby
Journal:  Am J Kidney Dis       Date:  2009-03-20       Impact factor: 8.860

9.  A truncating mutation in CEP55 is the likely cause of MARCH, a novel syndrome affecting neuronal mitosis.

Authors:  Patrick Frosk; Heleen H Arts; Julien Philippe; Carter S Gunn; Emma L Brown; Bernard Chodirker; Louise Simard; Jacek Majewski; Somayyeh Fahiminiya; Chad Russell; Yangfan P Liu; Robert Hegele; Nicholas Katsanis; Conrad Goerz; Marc R Del Bigio; Erica E Davis
Journal:  J Med Genet       Date:  2017-03-06       Impact factor: 6.318

10.  Cep55 regulates spindle organization and cell cycle progression in meiotic oocyte.

Authors:  Zhao-Yang Xu; Xue-Shan Ma; Shu-Tao Qi; Zhen-Bo Wang; Lei Guo; Heide Schatten; Qing-Yuan Sun; Ying-Pu Sun
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

View more
  9 in total

1.  Loss of Coiled-Coil Protein Cep55 Impairs Neural Stem Cell Abscission and Results in p53-Dependent Apoptosis in Developing Cortex.

Authors:  Jessica N Little; Katrina C McNeely; Nadine Michel; Christopher J Bott; Kaela S Lettieri; Madison R Hecht; Sara A Martin; Noelle D Dwyer
Journal:  J Neurosci       Date:  2021-02-23       Impact factor: 6.167

2.  [CEP55 may be a potential therapeutic target for non-obstructive azoospermia with maturation arrest].

Authors:  Yongtong Zhu; Junting Liu; Weiqing Zhang; Jiamin Wu; Wenfeng Li; Huixi Li; Qingjun Chu; Chen Luo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-09-30

3.  Delineating the expanding phenotype associated with SCAPER gene mutation.

Authors:  James Fasham; Gavin Arno; Siying Lin; Mingchu Xu; Keren J Carss; Sarah Hull; Amelia Lane; Anthony G Robson; Olivia Wenger; Jay E Self; Gaurav V Harlalka; Claire G Salter; Lynn Schema; Timothy J Moss; Michael E Cheetham; Anthony T Moore; F Lucy Raymond; Rui Chen; Emma L Baple; Andrew R Webster; Andrew H Crosby
Journal:  Am J Med Genet A       Date:  2019-06-13       Impact factor: 2.802

4.  Two NEMO-like Ubiquitin-Binding Domains in CEP55 Differently Regulate Cytokinesis.

Authors:  Keïs Nabhane Said Halidi; Elisabeth Fontan; Alix Boucharlat; Laurianne Davignon; Marine Charpentier; Mikaël Boullé; Robert Weil; Alain Israël; Emmanuel Laplantine; Fabrice Agou
Journal:  iScience       Date:  2019-09-25

5.  CEP55 promotes cilia disassembly through stabilizing Aurora A kinase.

Authors:  Yu-Cheng Zhang; Yun-Feng Bai; Jin-Feng Yuan; Xiao-Lin Shen; Yu-Ling Xu; Xiao-Xiao Jian; Sen Li; Zeng-Qing Song; Huai-Bin Hu; Pei-Yao Li; Hai-Qing Tu; Qiu-Ying Han; Na Wang; Ai-Ling Li; Xue-Min Zhang; Min Wu; Tao Zhou; Hui-Yan Li
Journal:  J Cell Biol       Date:  2021-02-01       Impact factor: 10.539

6.  Evidence that the Ser192Tyr/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B).

Authors:  Siying Lin; Aida Sanchez-Bretaño; Joseph S Leslie; Katie B Williams; Helena Lee; N Simon Thomas; Jonathan Callaway; James Deline; J Arjuna Ratnayaka; Diana Baralle; Melanie A Schmitt; Chelsea S Norman; Sheri Hammond; Gaurav V Harlalka; Sarah Ennis; Harold E Cross; Olivia Wenger; Andrew H Crosby; Emma L Baple; Jay E Self
Journal:  NPJ Genom Med       Date:  2022-01-13       Impact factor: 6.083

7.  Biallelic variants in TRAPPC10 cause a microcephalic TRAPPopathy disorder in humans and mice.

Authors:  Lettie E Rawlins; Hashem Almousa; Shazia Khan; Stephan C Collins; Miroslav P Milev; Joseph Leslie; Djenann Saint-Dic; Valeed Khan; Ana Maria Hincapie; Jacob O Day; Lucy McGavin; Christine Rowley; Gaurav V Harlalka; Valerie E Vancollie; Wasim Ahmad; Christopher J Lelliott; Asma Gul; Binnaz Yalcin; Andrew H Crosby; Michael Sacher; Emma L Baple
Journal:  PLoS Genet       Date:  2022-03-17       Impact factor: 5.917

8.  Cep55 overexpression promotes genomic instability and tumorigenesis in mice.

Authors:  Debottam Sinha; Purba Nag; Devathri Nanayakkara; Pascal H G Duijf; Andrew Burgess; Prahlad Raninga; Veronique A J Smits; Amanda L Bain; Goutham Subramanian; Meaghan Wall; John W Finnie; Murugan Kalimutho; Kum Kum Khanna
Journal:  Commun Biol       Date:  2020-10-21

Review 9.  Aurora A and AKT Kinase Signaling Associated with Primary Cilia.

Authors:  Yuhei Nishimura; Daishi Yamakawa; Takashi Shiromizu; Masaki Inagaki
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.